Skip to main content

Table 5 Comparison of oxidative stress parameters according to demographic variables

From: Oxidative stress and DNA damage in patients with migraine

Demographic variables

TAS (mmolTroloxEqv/L)

p value

TOS (mmolTroloxEqv/L)

p value

8-OHdG (ng/mL)

p value

Migraine

Control (n = 35)

 

Migraine

Control

 

Migraine

Control

 

Smoking

1.88 ± 0.45

1.82 ± 0.52

0.798

5.21 ± 3.8

4.06 ± 3.4

0.091

4.12 ± 1.2

3.31 ± 1.8

0.001*

Non-smoking

1.9 ± 0.89

1.94 ± 0.7

0.892

4.86 ± 3.2

3.94 ± 3.1

0.064

3.96 ± 1.08

2.98 ± 1.2

0.001*

p value

0.639

0.017

 

0.768

0.518

 

0.465

0.662

 

Female

1.7 ± 0.38

1.88 ± 0.62

0.164

4.82 ± 3.9

3.86 ± 2.9

0.065

3.92 ± 1.3

2.92 ± 1.8

0.001*

Male

1.9 ± 0.45

1.92 ± 0.48

0.692

4.99 ± 3.4

4.01 ± 3.7

0.074

4.19 ± 1.1

3.38 ± 1.4

0.001*

p value

0.598

0.765

 

0.794

0.684

 

0.235

0.085

 

Drugs (+)

1.93 ± 0.17

 

5.48 ± 3.8

 

4.16 ± 1.2

 

Drugs (−)

1.85 ± 0.14

 

4.49 ± 2.8

 

3.99 ± 3.2

 

p value

0.103

  

0.290

  

0.336

  
  1. Values are expressed as mean ± SD; TAS total antioxidant status, TOS total oxidant status, OSI oxidative stress ındex, 8-OHdG 8-hydroxy-2′-deoxyguanosine, SD standard deviation *p < 0.05
  2. Drug (+): Using symtometic migraine drugs (n = 24)
  3. Drug (−): Not using symtometic migraine drugs (n = 26)